Pharma - Q2FY24 - Earnings Preview
The Pharma companies under our coverage are likely to report aggregate Revenue/EBITDA/PAT growth of 17.4%/23.8%/25.2% YoY in Q2FY24E.
279 Views
Axis Top Picks - Oct 2023
We are proud to share that our Axis Top Picks basket delivered impressive returns of 32% in the last one year, beating by a wide margin the 15%...
560 Views
Axis Research Scorecard Report - August 2023
We are proud to share that we released several Top Sector Ideas during the month and we highly encourage you to refer to these exclusive reports
313 Views
Axis Top Picks for the month of September 2023
Axis Top Picks basket delivered impressive returns of 28% in the last one year, against the 8% return posted by Nifty 50, beating the benchmark by...
408 Views
Top Sector Ideas - Pharma
In Q1FY24, the Pharma Coverage universe posted robust revenue growth of 20.5%/6.1% YoY/QoQ on account of volume rampup, new launches (especially...
332 Views